Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty

Osteoarthritis (OA), a disease affecting different patient phenotypes, appears as an optimal candidate for personalized healthcare. The aim of the discussions of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group was to explore the value o...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Drugs Aging
Main Authors: Arden, Nigel, Richette, Pascal, Cooper, Cyrus, Bruyère, Olivier, Abadie, Eric, Branco, Jaime, Brandi, Maria Luisa, Berenbaum, Francis, Clerc, Cécile, Dennison, Elaine, Devogelaer, Jean-Pierre, Hochberg, Marc, D’Hooghe, Pieter, Herrero-Beaumont, Gabriel, Kanis, John A., Laslop, Andrea, Leblanc, Véronique, Maggi, Stefania, Mautone, Giuseppe, Pelletier, Jean-Pierre, Petit-Dop, Florence, Reiter-Niesert, Susanne, Rizzoli, René, Rovati, Lucio, Tajana Messi, Eleonora, Tsouderos, Yannis, Martel-Pelletier, Johanne, Reginster, Jean-Yves
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2015
Teme:
Current Opinion
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4516900/
https://ncbi.nlm.nih.gov/pubmed/26085027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-015-0276-7
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki